Elsevier expands biopharma base
Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. linkurl:Windhover;http://www.windhover.com/dotcom/home.asp publishes several journals, such as __In Vivo__, __Start-up__ and __The Regulation Policy Market Access Report__, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups. Acquiring Windhover adds more than 100 journalists to Elsevier's staff
Bob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
View Full Profile.
Learn about our Editorial Policies.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Meet the Author
Bob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.View full profile
Share
